Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study

Upregulation of programmed death ligand 1 (PD-L1) is a mechanism of immune escape utilized by a variety of tumors. PD-L1 expression in tumor cells or in the surrounding infiltrate correlates with clinical responsiveness to novel therapies targeting the PD-1/PD-L1 immune checkpoint. In the context of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncoimmunology
Main Authors: Mletzko, Salvinia, Pinato, David J., Robey, Rebecca C., Dalla Pria, Alessia, Benson, Peter, Imami, Nesrina, Bower, Mark
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2017
Teme:
Brief Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593697/
https://ncbi.nlm.nih.gov/pubmed/28919987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1304337
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki